U.S. market Closed. Opens in 8 hours 10 minutes

RAPT | RAPT Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 1.1500 - 1.2700
52 Week Range 1.0000 - 27.35
Beta 0.30
Implied Volatility 189.36%
IV Rank 57.26%
Day's Volume 284,907
Average Volume 534,101
Shares Outstanding 34,958,300
Market Cap 40,376,837
Sector Healthcare
Industry Biotechnology
IPO Date 2019-10-31
Valuation
Profitability
Growth
Health
P/E Ratio -0.42
Forward P/E Ratio N/A
EPS -2.78
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 122
Country USA
Website RAPT
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development of hematopoietic progenitor kinase 1 inhibitor. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
*Chart delayed
Analyzing fundamentals for RAPT we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see RAPT Fundamentals page.

Watching at RAPT technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on RAPT Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙